Literature DB >> 7514963

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.

G B Selby1, C Upchurch, J Townsend, H J Eyre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514963     DOI: 10.1007/bf00685938

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

Review 1.  Therapy of adult malignant brain tumors: what have the clinical trials taught us?

Authors:  W R Shapiro
Journal:  Semin Oncol       Date:  1986-03       Impact factor: 4.929

2.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

3.  Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).

Authors:  A Townsend; J M Leclerc; G Dutschman; D Cooney; Y C Cheng
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

4.  1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.

Authors:  R I Glazer; M C Knode
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

  4 in total
  1 in total

Review 1.  Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.

Authors:  Ricky Chen; Adam L Cohen; Howard Colman
Journal:  Curr Treat Options Oncol       Date:  2016-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.